|
CN104004817A
|
|
Selection of embryo of test tube baby through sequencing by single cell genome of polar body or embryo
|
|
CN102590314A
|
|
Method for decelerating nucleic acid molecules in solid nanopore
|
|
WO2008058297A2
|
|
Non-spherical particles
|
|
US2006078893A1
|
|
Compartmentalised combinatorial chemistry by microfluidic control
|
|
JP2003289887A
|
|
Immunomodulatory peptide
|
|
WO0039751A2
|
|
System and method for structure-based drug design that includes accurate prediction of binding free energy
|
|
US6248564B1
|
|
Mutant MHC class I molecules
|
|
US5317452A
|
|
Aligning and attaching a lens to a source of emitted light using light pressure force
|
|
JPH02288972A
|
|
Task management
|
|
US4900548A
|
|
Use of diethylcarbamazine to enhance antigen-antibody and antigen-host immune cell interactions
|
|
US4673737A
|
|
7-acylamino-(or 7-amino)-3-trifluoromethylsulfonyloxy-1-carba(1-dethia)-3-cephem-4-carboxylic acids and esters thereof
|
|
US4665171A
|
|
Process and intermediates for β-lactam antibiotics
|
